Real-world time to discontinuation of first-li... - CLL Support

CLL Support

22,987 members • 39,473 posts

Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma

1 year ago•7 Replies

You need to be a member of this community to see this post.

Read more about...

7 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters

Several of us have reported our CLL symptoms have come roaring back after discontinuing...

AussieNeilPartner•4 years ago

Debulking Eliminates Need for Hospitalization Prior to Initiating Venetoclax Therapy in untreated CLL pts

This is a report of Phase 3 study NCT03406156. Due to the rapid induction of cell death caused by...

Jm954Administrator•5 years ago

Encouraging results from venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

We've heard that re-treatment with venetoclax is possible. Per the attached image, here's some...

AussieNeilPartner•2 years ago

Acalabrutinib Plus Venetoclax and Obinutuzumab Achieves High Bone Marrow uMRD Rate in Chronic Lymphocytic Leukemia - CLL

Great news from this long awaited first published phase 2 study reporting the efficacy of this AVO...

AussieNeilPartner•3 years ago

A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lym

Background: Current therapies for CLL/SLL have frequent toxicities, are non-curative, and several...

CllcanadaTop Poster CURE Hero•6 years ago